David I. Sandoval
CIK: 0002012430
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (66.7%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Sandoval David I.
Sandoval David I. (SEC CIK 0002012430) files insider reports with the SEC as GC & Chief Compliance Officer of Milestone Pharmaceuticals Inc. (MIST) and GENERAL COUNSEL of MAXCYTE, INC. (MXCT).
Signal8 holds 4 ownership filings by Sandoval David I. (1 Form 3, 3 Form 4), filed between Jan 14, 2025 and Mar 23, 2026. Those filings report 3 transactions, from Jan 13, 2025 to Mar 18, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Sandoval David I.'s filings is in ROCKVILLE, MD.
Recent filings by Sandoval David I.
Other insiders filing for Milestone Pharmaceuticals Inc. (MIST)
- Giles Lisa M., Director
- Fischer Seth H. Z., Director
- Duty Stuart, Director
- Wills Robert James, Director
- TOMSICEK MICHAEL JOHN, Director
- Saik Andrew, Director